These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 4633166)

  • 21. Glomerular and dermal deposition of properdin in systemic lupus erythematosus.
    Rothfield N; Ross HA; Minta JO; Lepow IH
    N Engl J Med; 1972 Oct; 287(14):681-5. PubMed ID: 4115613
    [No Abstract]   [Full Text] [Related]  

  • 22. [Determination of properdin and complement factors].
    FRITZSCHE W; FISCHER H; SCHWICK G; SCHULTZE HE
    Klin Wochenschr; 1958 Feb; 36(3):100-7. PubMed ID: 13540128
    [No Abstract]   [Full Text] [Related]  

  • 23. Consumptive opsoninopathy: possible pathogenesis in lethal and opportunistic infections.
    Alexander JW; McClellan MA; Ogle CK; Ogle JD
    Ann Surg; 1976 Dec; 184(6):672-8. PubMed ID: 793541
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Validity and limitations in the determination of serum properdin by means of zymosan].
    ZANUSSI C; TASCHINI P; SELVA G; ORTOLANI C
    Boll Ist Sieroter Milan; 1958; 37(5-6):237-45. PubMed ID: 13560652
    [No Abstract]   [Full Text] [Related]  

  • 25. Methods for the assay of properdin.
    ISLIKER HC; LINDER E
    Vox Sang; 1958 Jan; 3(1):23-36. PubMed ID: 13544226
    [No Abstract]   [Full Text] [Related]  

  • 26. An improved properdin titration, based on the elimination of an inhibitor.
    WILLERS JM; PONDMAN KW; WINKLER KC
    Vox Sang; 1959 Feb; 4(1):21-32. PubMed ID: 13648265
    [No Abstract]   [Full Text] [Related]  

  • 27. An application of immunodiffusion to quantitative properdin estimation in human serum.
    Piertruska Z; Drozd J; Bogdanikowa B
    Clin Chim Acta; 1968 Jul; 21(1):139-42. PubMed ID: 4968888
    [No Abstract]   [Full Text] [Related]  

  • 28. Complement activation in semi-solid medium: Insolubilization of properdin and the third component of complement (C3) in agar gels.
    Ziegler JB; Watson L; Goodkofsky I; Alper CA; Lepow IH
    J Immunol; 1976 Jan; 116(1):75-9. PubMed ID: 812917
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Isolation of partially purified properdin from bovine serum by cold ethanol fractionation.
    MIYA F; MARCUS S
    Proc Soc Exp Biol Med; 1958 Oct; 99(1):247-9. PubMed ID: 13601831
    [No Abstract]   [Full Text] [Related]  

  • 30. [Properdin research. 2. Fractionation technics for obtaining highly purified bovine properdin and bovine properdin serum].
    Zimmermann G
    Arch Exp Veterinarmed; 1972 Oct; 26(5):705-31. PubMed ID: 4665861
    [No Abstract]   [Full Text] [Related]  

  • 31. [Determination of properdin in the blood serum].
    Pogrebniak LL; Svetlova LL; Truzhnikova TM; Ushchenko ID
    Veterinariia; 1975 Aug; (8):84-6. PubMed ID: 1216645
    [No Abstract]   [Full Text] [Related]  

  • 32. Allergen-reagin-mediated histamine release reactions.
    Malley A; Baecher L; Crossley G; Burger D
    Int Arch Allergy Appl Immunol; 1973; 44(1):122-39. PubMed ID: 4121288
    [No Abstract]   [Full Text] [Related]  

  • 33. [Quantitative estimation of properdin by the immunodiffusion method].
    Pietruska Z; Drozd J; Bogdanikowa B
    Rocz Akad Med Im Juliana Marchlewskiego Bialymst; 1969; 14():211-6. PubMed ID: 4989441
    [No Abstract]   [Full Text] [Related]  

  • 34. Interpretation of properdin levels determined by phage neutralization technique.
    COWAN KM
    Science; 1958 Oct; 128(3327):778-9. PubMed ID: 13592254
    [No Abstract]   [Full Text] [Related]  

  • 35. Mechanisms of activation of the properdin system. Studies on properdin electrophoretic mobility in agarose activation of the alternative pathway.
    Adam C; Williams DG; Peters DK
    Clin Exp Immunol; 1975 Nov; 22(2):240-8. PubMed ID: 813932
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Use of laser nephelometry in the measurement of complement components and associated factors (author's transl)].
    Nakajima N; Kan K; Sugisaki T
    Rinsho Byori; 1981 May; 29(5):507-10. PubMed ID: 6793751
    [No Abstract]   [Full Text] [Related]  

  • 37. [On the effect of surgical intervention on serum properdin levels].
    Shafran LM; Chinchenko EI
    Sov Med; 1967 May; 30(5):96-9. PubMed ID: 5612358
    [No Abstract]   [Full Text] [Related]  

  • 38. [Changes in serum properdin levels after effort in children with infantile cerebral paralysis].
    Eberhardt A; Lukomski S
    Acta Physiol Pol; 1968; 19(5):713-8. PubMed ID: 5701608
    [No Abstract]   [Full Text] [Related]  

  • 39. Relative importance of C3b inactivator and beta 1H globulin in the modulation of the properdin amplification loop in systemic lupus erythematosus.
    Whaley K; Schur PH; Ruddy S
    Clin Exp Immunol; 1979 Jun; 36(3):408-14. PubMed ID: 114347
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The properdin system and its role in infection and immunity. IV. Preparation of properdin from placental serum].
    NIKITINA VD; KHOLCHEV NV; CHERNOKHVOSTOVA EV; SOKHINA AM
    Zh Mikrobiol Epidemiol Immunobiol; 1962 Nov; 33():132-7. PubMed ID: 13938645
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.